Titre : Furanes

Furanes : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cluster Analysis
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Furanes : Questions médicales les plus fréquentes", "headline": "Furanes : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Furanes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-26", "dateModified": "2025-04-21", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Furanes" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Composés hétéromonocycliques", "url": "https://questionsmedicales.fr/mesh/D006573", "about": { "@type": "MedicalCondition", "name": "Composés hétéromonocycliques", "code": { "@type": "MedicalCode", "code": "D006573", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "4-Butyrolactone", "alternateName": "4-Butyrolactone", "url": "https://questionsmedicales.fr/mesh/D015107", "about": { "@type": "MedicalCondition", "name": "4-Butyrolactone", "code": { "@type": "MedicalCode", "code": "D015107", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.312.150" } } }, { "@type": "MedicalWebPage", "name": "Anhydrides citraconiques", "alternateName": "Citraconic Anhydrides", "url": "https://questionsmedicales.fr/mesh/D002949", "about": { "@type": "MedicalCondition", "name": "Anhydrides citraconiques", "code": { "@type": "MedicalCode", "code": "D002949", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.312.250" } } }, { "@type": "MedicalWebPage", "name": "Darunavir", "alternateName": "Darunavir", "url": "https://questionsmedicales.fr/mesh/D000069454", "about": { "@type": "MedicalCondition", "name": "Darunavir", "code": { "@type": "MedicalCode", "code": "D000069454", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.312.303" } } }, { "@type": "MedicalWebPage", "name": "Furfural", "alternateName": "Furaldehyde", "url": "https://questionsmedicales.fr/mesh/D005662", "about": { "@type": "MedicalCondition", "name": "Furfural", "code": { "@type": "MedicalCode", "code": "D005662", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.312.355" } } }, { "@type": "MedicalWebPage", "name": "Lasalocide", "alternateName": "Lasalocid", "url": "https://questionsmedicales.fr/mesh/D007832", "about": { "@type": "MedicalCondition", "name": "Lasalocide", "code": { "@type": "MedicalCode", "code": "D007832", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.312.490" } } }, { "@type": "MedicalWebPage", "name": "Anhydrides maléiques", "alternateName": "Maleic Anhydrides", "url": "https://questionsmedicales.fr/mesh/D008299", "about": { "@type": "MedicalCondition", "name": "Anhydrides maléiques", "code": { "@type": "MedicalCode", "code": "D008299", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.312.520" } } }, { "@type": "MedicalWebPage", "name": "Monensin", "alternateName": "Monensin", "url": "https://questionsmedicales.fr/mesh/D008985", "about": { "@type": "MedicalCondition", "name": "Monensin", "code": { "@type": "MedicalCode", "code": "D008985", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.312.600" } } }, { "@type": "MedicalWebPage", "name": "Naftidrofuryl", "alternateName": "Nafronyl", "url": "https://questionsmedicales.fr/mesh/D009257", "about": { "@type": "MedicalCondition", "name": "Naftidrofuryl", "code": { "@type": "MedicalCode", "code": "D009257", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.312.620" } } }, { "@type": "MedicalWebPage", "name": "Nitrofuranes", "alternateName": "Nitrofurans", "url": "https://questionsmedicales.fr/mesh/D009581", "about": { "@type": "MedicalCondition", "name": "Nitrofuranes", "code": { "@type": "MedicalCode", "code": "D009581", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.312.649" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "3-(2-(5-Nitro-2-furyl)vinyl)-1,2,4-oxadiazol-5-amine", "alternateName": "5-Amino-3-((5-nitro-2-furyl)vinyl)-1,2,4-oxadiazole", "url": "https://questionsmedicales.fr/mesh/D013184", "about": { "@type": "MedicalCondition", "name": "3-(2-(5-Nitro-2-furyl)vinyl)-1,2,4-oxadiazol-5-amine", "code": { "@type": "MedicalCode", "code": "D013184", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.312.649.200" } } }, { "@type": "MedicalWebPage", "name": "N-(4-(5-Nitro-2-furyl)-1,3-thiazol-2-yl)formamide", "alternateName": "FANFT", "url": "https://questionsmedicales.fr/mesh/D005200", "about": { "@type": "MedicalCondition", "name": "N-(4-(5-Nitro-2-furyl)-1,3-thiazol-2-yl)formamide", "code": { "@type": "MedicalCode", "code": "D005200", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.312.649.290" } } }, { "@type": "MedicalWebPage", "name": "Furagine", "alternateName": "Furagin", "url": "https://questionsmedicales.fr/mesh/D005661", "about": { "@type": "MedicalCondition", "name": "Furagine", "code": { "@type": "MedicalCode", "code": "D005661", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.312.649.308" } } }, { "@type": "MedicalWebPage", "name": "Furazolidone", "alternateName": "Furazolidone", "url": "https://questionsmedicales.fr/mesh/D005664", "about": { "@type": "MedicalCondition", "name": "Furazolidone", "code": { "@type": "MedicalCode", "code": "D005664", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.312.649.313" } } }, { "@type": "MedicalWebPage", "name": "2-(Furan-2-yl)-3-(5-nitrofuran-2-yl)prop-2-énamide", "alternateName": "Furylfuramide", "url": "https://questionsmedicales.fr/mesh/D005668", "about": { "@type": "MedicalCondition", "name": "2-(Furan-2-yl)-3-(5-nitrofuran-2-yl)prop-2-énamide", "code": { "@type": "MedicalCode", "code": "D005668", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.312.649.330" } } }, { "@type": "MedicalWebPage", "name": "Nifuratel", "alternateName": "Nifuratel", "url": "https://questionsmedicales.fr/mesh/D009545", "about": { "@type": "MedicalCondition", "name": "Nifuratel", "code": { "@type": "MedicalCode", "code": "D009545", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.312.649.410" } } }, { "@type": "MedicalWebPage", "name": "Nitrofurantoïne", "alternateName": "Nitrofurantoin", "url": "https://questionsmedicales.fr/mesh/D009582", "about": { "@type": "MedicalCondition", "name": "Nitrofurantoïne", "code": { "@type": "MedicalCode", "code": "D009582", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.312.649.566" } } }, { "@type": "MedicalWebPage", "name": "Nitrofural", "alternateName": "Nitrofurazone", "url": "https://questionsmedicales.fr/mesh/D009583", "about": { "@type": "MedicalCondition", "name": "Nitrofural", "code": { "@type": "MedicalCode", "code": "D009583", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.312.649.691" } } }, { "@type": "MedicalWebPage", "name": "Nitrovin", "alternateName": "Nitrovin", "url": "https://questionsmedicales.fr/mesh/D009610", "about": { "@type": "MedicalCondition", "name": "Nitrovin", "code": { "@type": "MedicalCode", "code": "D009610", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.312.649.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Ranitidine", "alternateName": "Ranitidine", "url": "https://questionsmedicales.fr/mesh/D011899", "about": { "@type": "MedicalCondition", "name": "Ranitidine", "code": { "@type": "MedicalCode", "code": "D011899", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.383.312.750" } } } ], "about": { "@type": "MedicalCondition", "name": "Furanes", "alternateName": "Furans", "code": { "@type": "MedicalCode", "code": "D005663", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Anja Rahn", "url": "https://questionsmedicales.fr/author/Anja%20Rahn", "affiliation": { "@type": "Organization", "name": "Zurich University of Applied Sciences, Institute of Chemistry and Biotechnology, Coffee Excellence Center & Analytical Technologies, Wädenswil, Switzerland. Electronic address: rahj@zhaw.ch." } }, { "@type": "Person", "name": "Chahan Yeretzian", "url": "https://questionsmedicales.fr/author/Chahan%20Yeretzian", "affiliation": { "@type": "Organization", "name": "Zurich University of Applied Sciences, Institute of Chemistry and Biotechnology, Coffee Excellence Center & Analytical Technologies, Wädenswil, Switzerland. Electronic address: yere@zhaw.ch." } }, { "@type": "Person", "name": "Yinbo Wan", "url": "https://questionsmedicales.fr/author/Yinbo%20Wan", "affiliation": { "@type": "Organization", "name": "Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education of China), Hunan Normal University, Changsha 410081, China." } }, { "@type": "Person", "name": "Haiyun Peng", "url": "https://questionsmedicales.fr/author/Haiyun%20Peng", "affiliation": { "@type": "Organization", "name": "Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education of China), Hunan Normal University, Changsha 410081, China." } }, { "@type": "Person", "name": "Guisheng Deng", "url": "https://questionsmedicales.fr/author/Guisheng%20Deng", "affiliation": { "@type": "Organization", "name": "Key Laboratory of Chemical Biology and Traditional Chinese Medicine Research (Ministry of Education of China), Hunan Normal University, Changsha 410081, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Structures of multivariables affecting literacy: Cluster analysis.", "datePublished": "2024-10-29", "url": "https://questionsmedicales.fr/article/39471203", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0310114" } }, { "@type": "ScholarlyArticle", "name": "Mapping, clustering, and analysis of research in psychiatric genomics.", "datePublished": "2022-10-21", "url": "https://questionsmedicales.fr/article/36302202", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/YPG.0000000000000325" } }, { "@type": "ScholarlyArticle", "name": "CAGECAT: The CompArative GEne Cluster Analysis Toolbox for rapid search and visualisation of homologous gene clusters.", "datePublished": "2023-05-03", "url": "https://questionsmedicales.fr/article/37131131", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12859-023-05311-2" } }, { "@type": "ScholarlyArticle", "name": "A topographical analysis of encephalocele locations: generation of a standardised atlas and cluster analysis.", "datePublished": "2023-03-10", "url": "https://questionsmedicales.fr/article/36897404", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00381-023-05883-7" } }, { "@type": "ScholarlyArticle", "name": "Phenotyping of atrial fibrillation with cluster analysis and external validation.", "datePublished": "2023-11-10", "url": "https://questionsmedicales.fr/article/37263768", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/heartjnl-2023-322447" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétéromonocycliques", "item": "https://questionsmedicales.fr/mesh/D006573" }, { "@type": "ListItem", "position": 4, "name": "Furanes", "item": "https://questionsmedicales.fr/mesh/D005663" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Furanes - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Furanes", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Furanes", "description": "Comment diagnostiquer une exposition aux furanes ?\nQuels tests sont utilisés pour détecter les furanes ?\nQuels symptômes indiquent une intoxication aux furanes ?\nY a-t-il des marqueurs biologiques pour les furanes ?\nComment évaluer le risque d'exposition aux furanes ?", "url": "https://questionsmedicales.fr/mesh/D005663?mesh_terms=Cluster+Analysis&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Furanes", "description": "Quels sont les symptômes d'une intoxication aiguë aux furanes ?\nLes furanes provoquent-ils des effets à long terme ?\nComment les furanes affectent-ils le système respiratoire ?\nY a-t-il des symptômes spécifiques chez les travailleurs exposés ?\nLes furanes affectent-ils le système immunitaire ?", "url": "https://questionsmedicales.fr/mesh/D005663?mesh_terms=Cluster+Analysis&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Furanes", "description": "Comment prévenir l'exposition aux furanes ?\nQuelles mesures de sécurité doivent être mises en place ?\nLes furanes peuvent-ils être évités dans l'industrie alimentaire ?\nQuelles sont les réglementations concernant les furanes ?\nLes travailleurs doivent-ils être formés sur les furanes ?", "url": "https://questionsmedicales.fr/mesh/D005663?mesh_terms=Cluster+Analysis&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Furanes", "description": "Quel est le traitement de l'intoxication aux furanes ?\nDes antidotes existent-ils pour les furanes ?\nComment traiter les irritations cutanées causées par les furanes ?\nLes soins d'urgence sont-ils nécessaires en cas d'exposition ?\nQuel suivi médical est recommandé après exposition ?", "url": "https://questionsmedicales.fr/mesh/D005663?mesh_terms=Cluster+Analysis&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Furanes", "description": "Quelles complications peuvent survenir après exposition aux furanes ?\nLes furanes peuvent-ils causer des cancers ?\nComment les furanes affectent-ils la reproduction ?\nLes furanes peuvent-ils affecter le foie ?\nY a-t-il des effets sur le système nerveux ?", "url": "https://questionsmedicales.fr/mesh/D005663?mesh_terms=Cluster+Analysis&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Furanes", "description": "Qui est le plus à risque d'exposition aux furanes ?\nLes fumeurs sont-ils plus à risque d'exposition ?\nLes enfants sont-ils plus vulnérables aux furanes ?\nQuels facteurs environnementaux augmentent le risque ?\nLes personnes ayant des antécédents médicaux sont-elles à risque ?", "url": "https://questionsmedicales.fr/mesh/D005663?mesh_terms=Cluster+Analysis&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une exposition aux furanes ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique d'exposition et des tests biologiques pour détecter des métabolites." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les furanes ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses de sang et d'urine peuvent être effectuées pour identifier les métabolites des furanes." } }, { "@type": "Question", "name": "Quels symptômes indiquent une intoxication aux furanes ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des nausées, des vomissements, des douleurs abdominales et des vertiges." } }, { "@type": "Question", "name": "Y a-t-il des marqueurs biologiques pour les furanes ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des marqueurs comme le 2-furylméthylcétone peuvent être mesurés dans les fluides corporels." } }, { "@type": "Question", "name": "Comment évaluer le risque d'exposition aux furanes ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Une évaluation des conditions de travail et des sources potentielles d'exposition est nécessaire." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une intoxication aiguë aux furanes ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes aigus incluent des maux de tête, des nausées, des irritations cutanées et respiratoires." } }, { "@type": "Question", "name": "Les furanes provoquent-ils des effets à long terme ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une exposition prolongée peut entraîner des effets chroniques comme des troubles neurologiques." } }, { "@type": "Question", "name": "Comment les furanes affectent-ils le système respiratoire ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent provoquer des irritations des voies respiratoires, des toux et des difficultés respiratoires." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques chez les travailleurs exposés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs peuvent présenter des symptômes comme des vertiges, des maux de tête et des troubles de la concentration." } }, { "@type": "Question", "name": "Les furanes affectent-ils le système immunitaire ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Une exposition prolongée peut altérer la réponse immunitaire, augmentant le risque d'infections." } }, { "@type": "Question", "name": "Comment prévenir l'exposition aux furanes ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des équipements de protection individuelle et suivre les protocoles de sécurité au travail." } }, { "@type": "Question", "name": "Quelles mesures de sécurité doivent être mises en place ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des systèmes de ventilation adéquats et des formations sur les risques chimiques sont essentiels." } }, { "@type": "Question", "name": "Les furanes peuvent-ils être évités dans l'industrie alimentaire ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en contrôlant les températures de cuisson et en évitant les méthodes de cuisson à haute température." } }, { "@type": "Question", "name": "Quelles sont les réglementations concernant les furanes ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des réglementations strictes existent pour limiter l'exposition professionnelle et environnementale." } }, { "@type": "Question", "name": "Les travailleurs doivent-ils être formés sur les furanes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une formation sur les risques et les mesures de sécurité est cruciale pour les travailleurs." } }, { "@type": "Question", "name": "Quel est le traitement de l'intoxication aux furanes ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement consiste à retirer la source d'exposition et à gérer les symptômes cliniques." } }, { "@type": "Question", "name": "Des antidotes existent-ils pour les furanes ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas d'antidote spécifique, le traitement est symptomatique et de soutien." } }, { "@type": "Question", "name": "Comment traiter les irritations cutanées causées par les furanes ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Il est recommandé de rincer la zone affectée et d'appliquer des crèmes apaisantes ou corticostéroïdes." } }, { "@type": "Question", "name": "Les soins d'urgence sont-ils nécessaires en cas d'exposition ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en cas de symptômes graves, une évaluation médicale urgente est nécessaire." } }, { "@type": "Question", "name": "Quel suivi médical est recommandé après exposition ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi régulier est conseillé pour surveiller les effets à long terme et la santé générale." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après exposition aux furanes ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des troubles respiratoires chroniques et des effets neurologiques." } }, { "@type": "Question", "name": "Les furanes peuvent-ils causer des cancers ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent un potentiel cancérigène, mais des recherches supplémentaires sont nécessaires." } }, { "@type": "Question", "name": "Comment les furanes affectent-ils la reproduction ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Une exposition peut entraîner des effets néfastes sur la reproduction et le développement fœtal." } }, { "@type": "Question", "name": "Les furanes peuvent-ils affecter le foie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une exposition peut entraîner des lésions hépatiques et des troubles fonctionnels du foie." } }, { "@type": "Question", "name": "Y a-t-il des effets sur le système nerveux ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une exposition prolongée peut causer des troubles neurologiques, y compris des neuropathies." } }, { "@type": "Question", "name": "Qui est le plus à risque d'exposition aux furanes ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les travailleurs dans l'industrie chimique et alimentaire sont les plus exposés aux furanes." } }, { "@type": "Question", "name": "Les fumeurs sont-ils plus à risque d'exposition ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut augmenter l'exposition aux furanes présents dans la fumée de cigarette." } }, { "@type": "Question", "name": "Les enfants sont-ils plus vulnérables aux furanes ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants peuvent être plus sensibles aux effets toxiques des furanes en raison de leur développement." } }, { "@type": "Question", "name": "Quels facteurs environnementaux augmentent le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "La pollution de l'air et la proximité d'industries émettrices de furanes augmentent le risque." } }, { "@type": "Question", "name": "Les personnes ayant des antécédents médicaux sont-elles à risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes avec des antécédents de maladies respiratoires ou hépatiques sont plus à risque." } } ] } ] }

Sources (10000 au total)

Mapping, clustering, and analysis of research in psychiatric genomics.

The distribution pattern and knowledge structure of psychiatric genomics were surveyed based on literature dealing with both psychiatry and genomics/genetics. Coword analysis and bibliographic couplin... The data were analyzed using coword analysis and clustering methods using Sci2 and VOSviewer.... Analysis of ~3800 records showed that psychiatric genomics is, as expectedly, covered largely under biomedical subjects with a visible interest in other disciplines such as humanities and ethics. A co... 'Schizophrenia', 'depression', 'pharmacogenomics', and 'immunopathogenesis' were the research topics of overarching interest. 'Gut-brain axis' and 'gene-environment interaction' were the emerging topi...

CAGECAT: The CompArative GEne Cluster Analysis Toolbox for rapid search and visualisation of homologous gene clusters.

Co-localized sets of genes that encode specialized functions are common across microbial genomes and occur in genomes of larger eukaryotes as well. Important examples include Biosynthetic Gene Cluster... The comparative gene cluster analysis toolbox (CAGECAT) is a rapid and user-friendly platform to mitigate difficulties in comparative analysis of whole gene clusters. The software provides homology se... Overall, CAGECAT is an extensible software that can be interfaced via a standard web-browser for whole region homology searches and comparison on continually updated genomes from NCBI. The public web ...

A topographical analysis of encephalocele locations: generation of a standardised atlas and cluster analysis.

Encephaloceles are considered to result from defects in the developing skull through which meninges, and potentially brain tissue, herniate. The pathological mechanism underlying this process is incom... Patients diagnosed with cranial encephaloceles or meningoceles were identified from a prospectively maintained database between 1984 and 2021. Images were transformed to atlas space using non-linear r... Of the 124 patients identified, 55 had volumetric imaging in the form of MRI (48/55) or CT (7/55) that could be used for atlas generation. Median encephalocele volume was 14,704 (IQR 3655-86,746) mm... This analysis revealed three predominant clusters for the location of encephaloceles, with the parieto-occipital junction being the most common. The stereotypic location of encephaloceles into anatomi...

Phenotyping of atrial fibrillation with cluster analysis and external validation.

Atrial fibrillation (AF) is a heterogeneous condition. We performed a cluster analysis in a cohort of patients with AF and assessed the prognostic implication of the identified cluster phenotypes.... We used two multicentre, prospective, observational registries of AF: the SAKURA AF registry (Real World Survey of Atrial Fibrillation Patients Treated with Warfarin and Non-vitamin K Antagonist Oral ... The analysis subclassified derivation cohort patients into five clusters. Cluster 1 (n=414, 13.6%) was characterised by younger men with a low prevalence of comorbidities; cluster 2 (n=1003, 32.8%) by... Machine learning-based cluster analysis identified five different phenotypes of AF with unique clinical characteristics and different clinical outcomes. The use of these phenotypes may help identify h...

Clinical phenotypes of chronic cough categorised by cluster analysis.

Chronic cough is a heterogeneous disease with various aetiologies that are difficult to determine. Our study aimed to categorise the phenotypes of chronic cough.... Adult patients with chronic cough were assessed based on the characteristics and severity of their cough using the COugh Assessment Test (COAT) and the Korean version of the Leicester Cough Questionna... In total, 255 participants were included in the analysis. Based on the correlation network, age, score for each item, and total COAT score were selected for the cluster analysis. Four clusters were id... Cluster analysis of age, score for each item, and total COAT score identified 4 distinct phenotypes of chronic cough with significant differences in the aetiologies. Subgrouping patients with chronic ...

Heterogeneity of asthma with nasal polyposis phenotypes: A cluster analysis.

Chronic rhinosinusitis with nasal polyposis (CRSwNP) affects a significant number of asthmatic patients and is notably associated with a more difficult-to-control asthma and marked inflammation. We ne... The aim of this study is to identify and characterize subphenotypes of asthma patients with CRSwNP using clinical, physiological and inflammatory variables.... K-means cluster analysis was performed on 17 clinical, physiological, and inflammatory variables from 1263 patients of all asthma severity and on a subpopulation of patients with asthma and CRSwNP. St... On the overall population, three groups were identified. Cluster T1 (n = 708) are young, have a short asthma duration and a low prevalence of CRSwNP. Cluster T2 (n = 263) have the longest asthma durat... Despite coexistence of asthma and CRSwNP, not all patients have the same evolution of their asthma. Different phenotypes of asthma with CRSwNP can be identified and exploration of the characteristics ...